Omega Fund V, L.P.

Omega Fund V, L.P. discloses dealings in 5 companies, chiefly Morphic Holding, Inc., Nuvation Bio Inc. and Gossamer Bio, Inc. The record holds 242 filings, for trades running from 12 February 2019 to 5 April 2022.

Market trades split into 3 purchases (€13.3M) and 230 sales (€100.7M). The net balance comes to €87.4M on the selling side. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Outside the open market, there are 1 share grant. So far in 2022, the count stands at no purchases and 1 sale.

A typical purchase (the median) is worth €4.3M. On 3 out of 3 purchases, another insider of the same company was buying within the same 30 days. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase.

The latest filing, published on 7 April 2022, reports an open-market sale of €12.8M in Nuvation Bio Inc. The last purchase on record was published on 16 October 2020, which is 2,214 days ago. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.